ADA Antikörper (AA 287-314)
Kurzübersicht für ADA Antikörper (AA 287-314) (ABIN3029872)
Target
Alle ADA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 287-314
-
Verwendungszweck
- ADA Antibody
-
Aufreinigung
- Protein G affinity
-
Immunogen
- A portion of amino acids 287-314 from the human protein was used as the immunogen for this ADA antibody.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Titration of the ADA antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the ADA antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ADA (Adenosine Deaminase (ADA))
-
Andere Bezeichnung
- ADA
-
Hintergrund
- This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.
-
UniProt
- P00813
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Ribonucleoside Biosynthetic Process
Target
-